Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.01
HEWA's Cash to Debt is ranked lower than
99% of the 371 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.62 vs. HEWA: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
HEWA' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 1.67 Max: No Debt
Current: 0.01
Equity to Asset -4.02
HEWA's Equity to Asset is ranked lower than
100% of the 370 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.43 vs. HEWA: -4.02 )
Ranked among companies with meaningful Equity to Asset only.
HEWA' s Equity to Asset Range Over the Past 10 Years
Min: -4.02  Med: 0.39 Max: 0.78
Current: -4.02
-4.02
0.78
F-Score: 4
Z-Score: -42.91
M-Score: -3.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -7.54
HEWA's Operating margin (%) is ranked lower than
93% of the 371 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.94 vs. HEWA: -7.54 )
Ranked among companies with meaningful Operating margin (%) only.
HEWA' s Operating margin (%) Range Over the Past 10 Years
Min: -66.04  Med: -43.08 Max: -7.55
Current: -7.54
-66.04
-7.55
Net-margin (%) -8.95
HEWA's Net-margin (%) is ranked lower than
92% of the 372 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.75 vs. HEWA: -8.95 )
Ranked among companies with meaningful Net-margin (%) only.
HEWA' s Net-margin (%) Range Over the Past 10 Years
Min: -64.86  Med: -51.40 Max: 2.81
Current: -8.95
-64.86
2.81
ROA (%) -49.46
HEWA's ROA (%) is ranked lower than
98% of the 373 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.19 vs. HEWA: -49.46 )
Ranked among companies with meaningful ROA (%) only.
HEWA' s ROA (%) Range Over the Past 10 Years
Min: -307.05  Med: -140.58 Max: 3.18
Current: -49.46
-307.05
3.18
ROC (Joel Greenblatt) (%) -90.63
HEWA's ROC (Joel Greenblatt) (%) is ranked lower than
97% of the 371 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.63 vs. HEWA: -90.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HEWA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -958.37  Med: -473.65 Max: -91.09
Current: -90.63
-958.37
-91.09
Revenue Growth (3Y)(%) -42.90
HEWA's Revenue Growth (3Y)(%) is ranked lower than
98% of the 317 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. HEWA: -42.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HEWA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.8  Med: -29.60 Max: 82.5
Current: -42.9
-61.8
82.5
EBITDA Growth (3Y)(%) -74.80
HEWA's EBITDA Growth (3Y)(%) is ranked lower than
99% of the 286 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.20 vs. HEWA: -74.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HEWA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -79.3  Med: -21.50 Max: 101.8
Current: -74.8
-79.3
101.8
EPS Growth (3Y)(%) -64.70
HEWA's EPS Growth (3Y)(%) is ranked lower than
99% of the 243 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.10 vs. HEWA: -64.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HEWA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -77.8  Med: -16.90 Max: 89.2
Current: -64.7
-77.8
89.2
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 2.15
HEWA's P/S is ranked lower than
91% of the 366 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.47 vs. HEWA: 2.15 )
Ranked among companies with meaningful P/S only.
HEWA' s P/S Range Over the Past 10 Years
Min: 0.26  Med: 1.21 Max: 29.92
Current: 2.15
0.26
29.92
Current Ratio 0.10
HEWA's Current Ratio is ranked lower than
100% of the 355 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.20 vs. HEWA: 0.10 )
Ranked among companies with meaningful Current Ratio only.
HEWA' s Current Ratio Range Over the Past 10 Years
Min: 0.1  Med: 1.32 Max: 3.42
Current: 0.1
0.1
3.42
Quick Ratio 0.06
HEWA's Quick Ratio is ranked lower than
100% of the 355 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.74 vs. HEWA: 0.06 )
Ranked among companies with meaningful Quick Ratio only.
HEWA' s Quick Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.81 Max: 3.08
Current: 0.06
0.06
3.08
Days Inventory 23.57
HEWA's Days Inventory is ranked higher than
70% of the 359 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 40.31 vs. HEWA: 23.57 )
Ranked among companies with meaningful Days Inventory only.
HEWA' s Days Inventory Range Over the Past 10 Years
Min: 15.79  Med: 30.08 Max: 141.52
Current: 23.57
15.79
141.52
Days Sales Outstanding 2.70
HEWA's Days Sales Outstanding is ranked higher than
84% of the 287 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.88 vs. HEWA: 2.70 )
Ranked among companies with meaningful Days Sales Outstanding only.
HEWA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.7  Med: 9.37 Max: 48.49
Current: 2.7
2.7
48.49
Days Payable 313.96
HEWA's Days Payable is ranked higher than
97% of the 299 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 46.29 vs. HEWA: 313.96 )
Ranked among companies with meaningful Days Payable only.
HEWA' s Days Payable Range Over the Past 10 Years
Min: 67.73  Med: 152.45 Max: 372.47
Current: 313.96
67.73
372.47

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.52
HEWA's Price/Median PS Value is ranked lower than
88% of the 322 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.10 vs. HEWA: 1.52 )
Ranked among companies with meaningful Price/Median PS Value only.
HEWA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.26  Med: 1.17 Max: 16.67
Current: 1.52
0.26
16.67
Price/Graham Number 1.25
HEWA's Price/Graham Number is ranked lower than
54% of the 280 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.52 vs. HEWA: 1.25 )
Ranked among companies with meaningful Price/Graham Number only.
HEWA' s Price/Graham Number Range Over the Past 10 Years
Min: 0.23  Med: 1.63 Max: 3.1
Current: 1.25
0.23
3.1
Earnings Yield (Greenblatt) (%) -2.60
HEWA's Earnings Yield (Greenblatt) (%) is ranked lower than
86% of the 368 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.50 vs. HEWA: -2.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HEWA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -2.95  Med: 21.80 Max: 162.9
Current: -2.6
-2.95
162.9

More Statistics

Revenue(Mil) $7
EPS $ -0.03
Beta-4.46
Short Percentage of Float0.00%
52-Week Range $0.09 - 0.50
Shares Outstanding(Mil)37.67

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:TSE:3417, BSE:RPH, TSE:2796, TSE:9776, ROCO:4173, HKSE:06108 » details
HealthWarehouse.com Inc was incorporated in the State of Delaware on August 5, 1998. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter medical products. The Company is presently licensed as a mail-order pharmacy for sales to 50 states in the United States and the District of Columbia. Currently, it sells prescription drugs both brand name and generic; diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering allergy and sinus to pain and fever to smoking cessation aids; diet and nutritional products including supplements, weight loss aids, and vitamins and minerals and pet medications. It also provides 90-day return policy with no restocking fees, and 100% free standard shipping on all orders. It sells directly to individual consumers who purchase prescription medications and OTC products. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's business is centered on Internet-based advertising. The Company filed for a trademark on the name HealthWarehouse.com on August 14, 2007 with the U.S. Patent and Trademark Office, which trademark was granted with a registration date of May 19, 2009. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.
» More Articles for HEWA

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 04 2016
HealthWarehouse.com to Present at the 3rd Annual Growth Capital Expo Microcap Investor Conference in... May 03 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Apr 21 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 06 2016
HEALTHWAREHOUSE.COM, INC. Financials Mar 31 2016
HealthWarehouse.com Reports 4th Quarter and 2015 Annual Results Mar 31 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-K, Annual Report Mar 25 2016
CORRECTING and REPLACING HealthWarehouse.com Only Certified Online Pharmacy to Sell Prescriptions on... Feb 22 2016
HealthWarehouse.com Only Certified Online Pharmacy to Sell Prescriptions on Google Feb 16 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 25 2016
HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital Jan 25 2016
CORRECTING and REPLACING HealthWarehouse.com Featured in U.S. News & World Report as Reliable, Cost... Jan 14 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Jan 14 2016
HealthWarehouse.com Appoints Daniel Seliga as Chief Operating Officer and Chief Financial Officer Jan 14 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct... Dec 10 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 17 2015
HealthWarehouse.Com Reports 14.5% Quarterly Sales Growth Year over Year Nov 17 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report Nov 13 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 12 2015
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 19 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK